Hacker News new | ask | show | jobs
by terio 2208 days ago
The WHO already restarted studies involving hydroxychloroquine.

>> Who is liable for their denial of treatment?

Doctors base their treatments on the best information they have at hand. In many cases, that information turns out to be faulty.

This retraction does not mean the HCQ works against COVID-19, only that this particular study is no proof that it does not work.

1 comments

Hydroxychloroquine does not repair damaged cells, but it does stop the virus from replicating (especially when used with Zinc)

There are five scientific studies demonstrating this for outpatient use.

https://academic.oup.com/aje/advance-article/doi/10.1093/aje...

Since this is being repeated multiple times, quoting benmaraschino:

One of these "studies" is a 2-page Google Doc with no real data. Another is the discredited Raoult study, which is under investigation by the journal [1]. Another study cited is also by Raoult's team. The Brazil study (ref. 29) doesn't seem to have passed peer review (yet?) and has severe methodological flaws. Like the Raoult studies, the Brazil study was not randomized, but makes no attempt to control for confounding by indication or self-selection, such as with propensity score matching or similar methods commonly used in observational studies. The last study cited isn't a study, but an article from a local news station.

I believe Hydroxychroloquine is used as a prophylaxis in India and possibly other countries. Have there been any studies on that?

The death toll (CFR) in India is suspiciously lower than in the European states. Could it be because they're using Hydroxychroloquine more freely [0]? Though, that hasn't been without controversy [1].

[0] https://medicalxpress.com/news/2020-05-india-hydroxychloroqu...

[1] https://science.thewire.in/health/covid-19-indian-council-of...

I came across this:

>According to the ICMR study published in the Indian Journal of Medical Research (IJMR), consumption of four or more maintenance doses was associated with a significant decline (>80%) in the risk of Covid-19 infection among the ‘participants’. The study also found that there was no significant association between HCQ and adverse drug reactions.

https://health.economictimes.indiatimes.com/news/pharma/why-...

Link to the preliminary paper http://www.ijmr.org.in/preprintarticle.asp?id=285520

> The death toll (CFR) in India is suspiciously lower than in the European states

There are too many other, far more plausible, reasons why the death toll in India looks lower:

* Population pyramid - far fewer people aged 70+ as a percentage of the population means a far lower CFR

* Hotter weather which slows the spread of coronaviruses massively

* More sunlight means less vitamin-D deficiency (which seems to worsen infections)

* Low amount of travel to/from initial seeding spots means closing borders was effective (Wuhan, northern Italy, Alps)

And that is without casting any aspersions about causes of death being attributed correctly.

Come back, zinc!